| 1 |
Key steps of the cis-platin-DNA interaction: Density functional theory-based molecular dynamics simulations
Carloni P, Sprik M, Andreoni W
Journal of Physical Chemistry B, 104(4), 823, 2000 |
| 2 |
Retro models of Pt anticancer drug DNA adducts: Chirality-controlling chelate ligand restriction of guanine dynamic motion in (2,2 '-Bipiperidine)PtG(2) complexes (G = guanine derivative)
Ano SO, Intini FP, Natile G, Marzilli LG
Inorganic Chemistry, 38(12), 2989, 1999 |
| 3 |
Effects of six-membered-ring conformation on the rotamer distribution and rate of atropisomerization in platinum(II)-guanine compounds : 2,4-bis(methylamino)pentane complexes
Williams KM, Cerasino L, Intini FP, Natile G, Marzilli LG
Inorganic Chemistry, 37(20), 5260, 1998 |
| 4 |
Model of the 2nd Most Abundant Cisplatin-DNA Cross-Link - X-Ray Crystal-Structure and Conformational-Analysis of Cis-((NH3)(2)Pt(9-Mea-N7)) (9-Etgh-N7)(NO3)Center-Dot-2H(2)O (9-Mea=9-Methyladenine, 9-Etgh=9-Ethylguanine)
Schroder G, Kozelka J, Sabat M, Fouchet MH, Beyerlepfnur R, Lippert B
Inorganic Chemistry, 35(6), 1647, 1996 |
| 5 |
Dinuclear Platinum Complexes Form a Novel Intrastrand Adduct with D(Gpg), an Anti-Syn Conformation of the Macrochelate as Observed by NMR and Molecular Modeling
Qu Y, Bloemink MJ, Reedijk J, Hambley TW, Farrell N
Journal of the American Chemical Society, 118(39), 9307, 1996 |
| 6 |
Crystal-Structure of the Anticancer Drug Cisplatin Bound to Duplex DNA
Takahara PM, Frederick CA, Lippard SJ
Journal of the American Chemical Society, 118(49), 12309, 1996 |
| 7 |
Cancer-Chemotherapy - Heavy-Metal Revival
Petsko GA
Nature, 377(6550), 580, 1995 |
